Clinical Trials Directory

Trials / Completed

CompletedNCT02537730

BIOCLEAN MPS (Multi-Purpose Solution) VII in Combination With Biofinity Lens: A Two Week Crossover Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
33 (actual)
Sponsor
CooperVision, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Two week, Open Label, randomized, bilateral, crossover, 1 week of daily wear in each combination (lens / disinfecting cleaning system).

Detailed description

To determine if patients are unreactive to the lens care solution / Biofinity combination. It is expected that there will be a total of three visits: V1 (Initial), V2 (1 week), \& V3 (2 weeks).

Conditions

Interventions

TypeNameDescription
DEVICEBioclean MPS VIIPHMB (Polyhexamethylene biguanide) base Disinfecting and Cleaning system
DEVICEAosept ClearcareHydrogen Peroxide Disinfecting and Cleaning system
DEVICEcomfilcon Acontact lens

Timeline

Start date
2015-09-01
Primary completion
2015-10-01
Completion
2016-06-01
First posted
2015-09-02
Last updated
2020-08-18
Results posted
2016-09-20

Locations

3 sites across 1 country: Japan

Regulatory

Source: ClinicalTrials.gov record NCT02537730. Inclusion in this directory is not an endorsement.

BIOCLEAN MPS (Multi-Purpose Solution) VII in Combination With Biofinity Lens: A Two Week Crossover Study (NCT02537730) · Clinical Trials Directory